Definitive Contract 75D30122C14776
Award Date
8/31/22
Potential Completion Date
8/30/23
Potential Value
$639K
Federal Agency
CDC Pittsburgh
Awardee
University Of Texas At Austin
Ultimate Awardee
Not listed
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78759, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a Definitive Contract with a ceiling value of $734,730.60 issued by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, a civilian agency. The contract was awarded to the University of Texas at Austin, a public research university, to perform work under Broad Agency Announcement (BAA) Topic 20.2 - "Estimating the Effects of COVID-19 Non-Pharmaceutical Interventions on the Burden of Influenza in the U.S." The University of Texas...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Texas at Austin, a non-profit public research university, for a contract valued at $401,203.00. The contract is for the development of a "Modeling Toolkit to Evaluate Multifaceted Control Strategies for Seasonal and Pandemic Influenza." This project will utilize modeling and forecasting tools to improve the U.S. response to...
This federal contract award, valued at $250,000.00, was granted by the Centers for Disease Control and Prevention (CDC) to the University of Texas at Austin (UT Austin). The contract is for the "STRENGTHENING PERTUSSIS SURVEILLANCE AND DIAGNOSTICS BY IMPROVEMENTS IN ANTIGEN PRODUCTION", with a period of performance ending on September 29, 2026. The contract is a definitive contract with a cost-no-fee pricing type, and there is no set-aside designation. As a major research university,...
The Centers for Disease Control and Prevention (CDC) awarded a $699,118 cost-no-fee definitive contract to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) to conduct research on agricultural pathogens. As the prime contractor, UGA Research Foundation will perform the work at its location in Athens, Georgia over a two-year period starting September 1, 2020 through August 31, 2022. The contract was awarded under an unspecified vehicle by the CDC Pittsburgh office to...
The University of Georgia Research Foundation, Inc. was awarded a firm fixed price purchase order totaling $182,648.24 by the Centers for Disease Control and Prevention located in Atlanta, Georgia. The contract is for remote access time and facilities with no set aside designation specified. Performance will take place in Atlanta through September 2023. As the prime contractor, the University of Georgia Research Foundation will provide research support services to the Centers for Disease Control...
The University of Georgia Research Foundation, Inc. was awarded a firm fixed price, definite contract valued at one million, one hundred sixteen thousand, five hundred thirty-nine dollars ($1,116,539) by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. The contract is for SARS-COV-2 applied research with a period of performance through January 31, 2023 and no set aside designation was used. Major subcontracting support is being provided by the...
This federal contract award, valued at $846,421.00, was granted to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization that facilitates sponsored research and technology transfer activities for the University of Georgia. The contract is for Research and Development (R&D) services and was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract does not have a set-aside designation...
This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation). The contract has a potential value of $507,953.63 and is a definitive, firm fixed-price contract without any set-aside designation. The contract is for "Other Functions", which implies a broad scope of work. Based on UGA Research Foundation's background, it appears they are...
The Centers for Disease Control and Prevention awarded a $94,061 firm fixed price purchase order to the Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs, for molecular dynamics modeling services. The contract has a period of performance from September 2023 through September 2026. The work will be conducted at the prime contractor's location in Chamblee, Georgia and supports the CDC's disease prevention programs through computational modeling and simulation....
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a Firm Fixed Price Definitive Contract with a ceiling value of $949,898.00 to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) for FY 21 BAA TOPIC 8. The contract has an ultimate completion date of June 30, 2024 and was awarded on June 1, 2021. UGA Research Foundation is a non-profit organization that facilitates sponsored research, education, and outreach initiatives for the University of Georgia....